Ward 21 CRS Hosts BIYELA Protocol Training

The Wits RHI Research Team at Ward 21 CRS, under the leadership of Prof Sinead Delany-Moretlwe, Director of Research at Wits RHI, recently hosted a delegation from the Bill & Melinda Gates Foundation and the University of Washington. The visiting team included Dr. Lori Newman, Deputy Director of STI & Gynecology, and Dr. Lyou-Fu Ma, Portfolio and Platform Lead from the Bill & Melinda Gates Foundation, as well as Prof. Connie Cellum and her team from the University of Washington.

This site visit provided an in-depth look at the upcoming Biyela study, a Phase 3 randomized, double-blinded, placebo-controlled trial. The Biyela study is designed to evaluate the efficacy of the Meningococcal Serogroup B Vaccine (Bexsero) in preventing gonococcal infection among individuals born female in South Africa.